Morning Market Movers

Sarepta Therapeutics

shares advanced 100.20% to $30.01 at 9:45 am. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients. BIOLASE

climbed 22.29% to $2.03. BIOLASE has received clearance from the FDA and Conformité Européene Mark approval for its EPIC 10™ diode soft tissue laser. Ocwen Financial

surged 15.40% to $33.42. Ocwen Financial announced its plans to acquire Homeward Residential Holdings from WL Ross & Co LLC. BioLineRx Ltd

surged 14.84% to $2.9972. BioLineRx shares have dropped 23.91% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period.